Advanced SearchSearch Tips
Screening for Lynch Syndrome in Young Colorectal Cancer Patients from Saudi Arabia Using Microsatellite Instability as the Initial Test
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
Screening for Lynch Syndrome in Young Colorectal Cancer Patients from Saudi Arabia Using Microsatellite Instability as the Initial Test
Alqahtani, Masood; Grieu, Fabienne; Carrello, Amerigo; Amanuel, Benhur; Mashour, Miral; Alattas, Rabab; Al-Saleh, Khalid; Alsheikh, Abdulmalik; Alqahtani, Sarah; Iacopetta, Barry;
  PDF(new window)
Background: Lynch Syndrome (LS) is a familial cancer condition caused by germline mutations in DNA mismatch repair genes. Individuals with LS have a greatly increased risk of developing colorectal cancer (CRC) and it is therefore important to identify mutation carriers so they can undergo regular surveillance. Tumor DNA from LS patients characteristically shows microsatellite instability (MSI). Our aim here was to screen young CRC patients for MSI as a first step in the identification of unrecognized cases of LS in the Saudi population. Materials and Methods: Archival tumor tissue was obtained from 284 CRC patients treated at 4 institutes in Dammam and Riyadh between 2006 and 2015 and aged less than 60 years at diagnosis. MSI screening was performed using the BAT-26 microsatellite marker and positive cases confirmed using the pentaplex MSI analysis system. Positive cases were screened for BRAF mutations to exclude sporadic CRC and were evaluated for loss of expression of 4 DNA mismatch repair proteins using immunohistochemistry. Results: MSI was found in 33/284 (11.6%) cases, of which only one showed a BRAF mutation. Saudi MSI cases showed similar instability in the BAT-26 and BAT-25 markers to Australian MSI cases, but significantly lower frequencies of instability in 3 other microsatellite markers. Conclusions: MSI screening of young Saudi CRC patients reveals that approximately 1 in 9 are candidates for LS. Patients with MSI are strongly recommended to undergo genetic counselling and germline mutation testing for LS. Other affected family members can then be identified and offered regular surveillance for early detection of LS-associated cancers.
Colorectal cancer;microsatellite instability;Lynch syndrome;screening;Saudi Arabia;
 Cited by
A new hereditary colorectal cancer network in the Middle East and eastern mediterranean countries to improve care for high-risk families, Familial Cancer, 2017, 1573-7292  crossref(new windwow)
Screening for Lynch syndrome in young Saudi colorectal cancer patients using microsatellite instability testing and next generation sequencing, Familial Cancer, 2017, 1573-7292  crossref(new windwow)
Aljebreen AM (2007). Clinico-pathological patterns of colorectal cancer in Saudi Arabia: younger with an advanced stage presentation. Saudi J Gastroenterol, 13, 84-87. crossref(new window)

Al-Madouj A, Hayder M, Al-Zahrani W, et al (2011). Cancer incidence report saudi arabia. Saudi Cancer Registry 2011. Pages/CancerRegistryRecords.aspx

Amin TT, Suleman W, Al Taissan AA, et al (2012). Patients’ profile, clinical presentations and histopathological features of colo-rectal cancer in Al Hassa region, Saudi Arabia. Asian Pac J Cancer Prev, 13, 211-6. crossref(new window)

Beg S, Siraj AK, Prabhakaran S, et al (2015). Molecular markers and pathway analysis of colorectal carcinoma in the Middle East. Cancer. 121, 3799-808. crossref(new window)

Domingo E, Laiho P, Ollikainen M, et al (2004). BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet, 41, 664-8. crossref(new window)

el-Hazmi MA, al-Swailem AR, Warsy AS, et al (1995). Consanguinity among the Saudi Arabian population. J Med Genet, 32, 623-26. crossref(new window)

Elsamany SA, Alzahrani AS, Mohamed MM, et al (2014). Clinico-pathological patterns and survival outcome of colorectal cancer in young patients: western Saudi Arabia experience. Asian Pac J Cancer Prev, 15, 5239-43. crossref(new window)

Iacopetta B, Grieu F (2000). Routine detection of the replication error phenotype in clinical tumor specimens using fluorescence-SSCP. Biotechniques, 28, 566-70.

Iacopetta B, Grieu F, Amanuel B (2010). Microsatellite instability in colorectal cancer. Asia Pac J Clin Oncol, 6, 260-9. crossref(new window)

Ibrahim EM, Zeeneldin AA, El-Khodary TR, et al (2008). Past, present and future of colorectal cancer in the Kingdom of Saudi Arabia. Saudi J Gastroenterol, 14, 178-82. crossref(new window)

Jarvinen HJ, Aarnio M, Mustonen H, et al (2000). Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterol, 118, 829-34. crossref(new window)

Li WQ, Kawakami K, Ruszkiewicz A, et al (2006). BRAF mutations are associated with distinctive clinical, pathological and molecular features of colorectal cancer independently of microsatellite instability status. Mol Cancer, 5, 2. crossref(new window)

Lynch HT, de la Chapelle A (2003). Hereditary colorectal cancer. N Engl J Med, 348, 919-32. crossref(new window)

Lynch HT, Riley BD, Weissman SM, et al (2004). Hereditary nonpolyposis colorectal carcinoma (HNPCC) and HNPCClike families: Problems in diagnosis, surveillance, and management. Cancer, 100, 53-64. crossref(new window)

Marcus VA, Madlensky L, Gryfe R, et al (1999). Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors. Am J Surg Pathol, 23, 1248-55. crossref(new window)

Mosli MH, Al-Ahwal MS (2012). Colorectal cancer in the Kingdom of Saudi Arabia: need for screening. Asian Pac J Cancer Prev, 13, 3809-13. crossref(new window)

Nemati A, Rahmatabadi ZK, Fatemi A, Emami MH (2011). Hereditary non-polyposis colorectal cancer and familial colorectal cancer in central part of Iran, Isfahan. J Res Med Scien, 17, 67-73.

Pinol V, Castells A, Andreu M, et al (2005). Gastrointestinal oncology group of the spanish gastroenterological association. accuracy of revised bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA, 293, 1986-94. crossref(new window)

Richter A, Grieu F, Carrello A, et al (2013). A multisite blinded study for the detection of BRAF mutations in formalin-fixed, paraffin-embedded malignant melanoma. Sci Rep, 3, 1659. crossref(new window)

Samowitz WS, Curtin K, Lin HH, et al (2001). The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer. Gastroenterol, 121, 830-8. crossref(new window)

Schofield L, Watson N, Grieu F, et al (2009). Population-based detection of Lynch syndrome in young colorectal cancer patients using microsatellite instability as the initial test. Int J Cancer, 124, 1097-102. crossref(new window)

Schofield L, Grieu F, Amanuel B, et al (2014). Population-based screening for Lynch syndrome in Western Australia. Int J Cancer, 135, 1085-91. crossref(new window)

Siraj AK, Bu R, Prabhakaran S, et al (2014). A very low incidence of BRAF mutations in Middle Eastern colorectal carcinoma. Mol Cancer, 13, 168. crossref(new window)

Siraj AK, Prabhakaran S, Bavi P, et al (2015). Prevalence of Lynch syndrome in a Middle Eastern population with colorectal cancer. Cancer, 121, 1762-71. crossref(new window)

Snowsill T, Huxley N, Hoyle M, et al (2015). A model-based assessment of the cost-utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients. BMC Cancer, 15, 313. crossref(new window)

Suraweera N, Duval A, Reperant M, et al (2002). Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR. Gastroenterolo, 123, 1804-11. crossref(new window)

Terdiman JP (2005). It is time to get serious about diagnosing Lynch syndrome (hereditary nonpolyposis colorectal cancer with defective DNA mismatch repair) in the general population. Gastroenterol, 129, 741-4. crossref(new window)

Umar A, Boland CR, Terdiman JP, et al (2004). Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst, 96, 261-8. crossref(new window)

Ward RL, Hicks S, Hawkins NJ (2013). Population-based molecular screening for Lynch syndrome: implications for personalized medicine. J Clin Oncol, 31, 2554-2562. crossref(new window)

Xicola RM, Llor X, Pons E, et al (2007). Gastrointestinal oncology group of the spanish gastroenterological association. performance of different microsatellite marker panels for detection of mismatch repair-deficient colorectal tumors. J Natl Cancer Inst, 99, 244-52. crossref(new window)

Zeinalian M, Hashemzadeh-Chaleshtori M, Akbarpour MJ, et al (2015). Epidemioclinical feature of early-onset colorectal cancer at-risk for Lynch syndrome in central Iran. Asian Pac J Cancer Prev, 16, 4647-52. crossref(new window)